RPID
NASDAQ · Life Sciences Tools & Services
Rapid Micro Biosystems Inc-A
$2.48
-0.10 (-3.88%)
Financial Highlights (FY 2026)
Revenue
32.18M
Net Income
-45,156,274
Gross Margin
3.1%
Profit Margin
-140.3%
Rev Growth
+25.2%
D/E Ratio
0.57
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 3.1% | 3.1% | 67.1% | 67.1% |
| Operating Margin | -141.1% | -127.0% | 15.2% | 14.6% |
| Profit Margin | -140.3% | -133.3% | 15.7% | 16.6% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 32.18M | 25.71M | 48.80M | 45.04M |
| Gross Profit | 1.00M | 802.3K | 32.74M | 30.22M |
| Operating Income | -45,410,963 | -32,654,096 | 7.43M | 6.55M |
| Net Income | -45,156,274 | -32,470,954 | 7.65M | 7.46M |
| Gross Margin | 3.1% | 3.1% | 67.1% | 67.1% |
| Operating Margin | -141.1% | -127.0% | 15.2% | 14.6% |
| Profit Margin | -140.3% | -133.3% | 15.7% | 16.6% |
| Rev Growth | +25.2% | +25.2% | +18.7% | +19.0% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 19.38M | 19.38M | 38.69M | 38.35M |
| Total Equity | 33.71M | 33.71M | 134.82M | 132.50M |
| D/E Ratio | 0.57 | 0.57 | 0.29 | 0.29 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -42,403,313 | -32,185,320 | 9.93M | 10.62M |
| Free Cash Flow | — | — | 5.64M | 3.34M |